The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia by Yesid Alvarado-Valero, Rachel J. Cook, Shira N. Dinner, Michael Keng, Kebede H. Begna, Nathalie Javidi-Sharifi, Sameem Abedin, Monzr M. Al Malki, Vijaya Raj Bhatt, Prabhu Rajagopalan, Min Tang, Sandra E. Wiley, Richard G. Ghalie, Matthew S. Davids

Get full text

Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase by Joseph F. Mort, David Brighton, Benjamin Mautner, Eric Pierce, Farid Ghamsari, Cecily Allen, Darren D’Souza, Imari Patel, Justin Lawson, Clayton Jackson, Karin Abernathy, Bradley Yelvington, Ryan Miller, Bhagirathbhai Dholaria, Heather Wolfe, Jordan Infield, Susan C. Locke, Rory M. Shallis, Vu H. Duong, Daniel R. Reed, Katherine Walsh, Thomas W. LeBlanc, Michael Keng, Bethany Horton, Firas El Chaer

Get full text